MétaCan
Menu
Back to cohort
Record W4248458635 · doi:10.1093/ibd/izy393.028

P024 PATIENT AND HEALTHCARE PROVIDER VIEWS ON ULCERATIVE COLITIS TREATMENT GOALS AND QUALITY OF LIFE: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY

2019· article· en· W4248458635 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

aboutThe title or abstract carries a Canadian signal from the geographic lexicon.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueInflammatory Bowel Diseases · 2019
Typearticle
Languageen
FieldMedicine
TopicMicroscopic Colitis
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineUlcerative colitisMedical prescriptionInternal medicineQuality of life (healthcare)Family medicineColectomyHealth careDiseaseNursing

Abstract

fetched live from OpenAlex

The Ulcerative Colitis (UC) Narrative is a global survey of patients (pts) and gastroenterology physicians (GIs) aimed at identifying the impact of UC and comparing and contrasting perceptions of UC burden and management approaches. Here, we focus on pt and GI expectations of UC management and establishing treatment goals, and present data from 2100 pts and 1254 GIs in Australia, Canada, Finland, France, Germany, Italy, Japan, Spain, the UK, and the USA. Surveys were conducted online and by phone by The Harris Poll between August 2017 and February 2018. Adult pts with UC (confirmed by endoscopy) who had visited a GI in the previous 12 months and had ever received prescription medication for UC were eligible for inclusion. Self-reported medication history was used as a proxy for disease severity. Pts with moderate to severe UC were those who had ever taken immunosuppressants, tumor necrosis factor inhibitors, other biologics, or corticosteroids for >4 of the past 12 months. Pts who had only ever taken 5-aminosalicylates or had a colectomy were excluded. Eligible GIs were those who saw ≥10 UC pts each month (≥5 in Japan), of whom ≥10% were taking a biologic and did not practice in a long-term care facility or hospice. Data are presented from all respondents who consented and completed the survey. Pts had a mean age of 40.8 (standard deviation [SD] 12.4) years and 53% were male. Most pts (82%) had moderate to severe UC and 67% described their UC as being controlled with few to no symptoms. GIs had been in specialty practice for a mean of 16.4 (SD 8.4) years and saw a mean of 40 pts with UC each month. Most pts (65%) felt that UC controlled their life rather than them controlling their disease, including significant time spent in the bathroom, with 67% feeling that they spend more time in the bathroom than anywhere else. More than a third of pts (35%) wished that their GI better understood the impact of UC on their quality of life (QoL). Pts and GIs generally agreed that the ability to perform daily activities and ability to control pain were among the most important aspects of UC management for pts (Table). While, globally, 71% of pts had set goals for managing their UC with their GI, this varied by country; highest in Australia (82%), Italy (82%) and Spain (84%) and lowest in the UK (51%). Only 58% of GIs discussed pts’ lifestyle goals as part of UC management. Pts (62%) and GIs (72%) alike expressed a desire for greater discussion on goals. Pts and GIs agree that QoL and the ability to control pain are central to UC management. The importance of treatment goals is recognized by pts and GIs, with many pts identifying aspects important to them for managing their UC. Improved pt-to-GI communication should enable effective goal setting, and thus enhance pt experience and disease outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.332
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it